• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发新型二苯乙烯和大环化合物衍生物作为有效的微管抑制剂。

Development of novel derivatives of stilbene and macrocyclic compounds as potent of anti-microtubule factors.

机构信息

Department of Organic Chemistry, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664, Warsaw, Poland; The Nencki Institute of Experimental Biology Polish Academy of Sciences, Poland.

Department of Organic Chemistry, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, 00-664, Warsaw, Poland.

出版信息

Biomed Pharmacother. 2021 Jan;133:110973. doi: 10.1016/j.biopha.2020.110973. Epub 2020 Dec 2.

DOI:10.1016/j.biopha.2020.110973
PMID:33378993
Abstract

Microtubules (composed of α- and β-tubulin heterodimers) ubiquitous cellular polymers are important components of the cytoskeleton and play diverse roles within the cell, such as maintenance of cell structure, protein trafficking or chromosomal segregation during cell division. The polymers of tubulin play a pivotal role in mitosis and are regarded as an excellent target for chemotherapeutic agents to treat cancer. This review presents a brief overview of the synthesis and mechanism of action of new compounds targeting the dynamic of microtubule - tubulin polymerization/depolymerization. It is divided into the following parts: section I concerns targeting microtubules- tubulin-binding drugs derivatives of stilbene. In section II there are presented photoswitchable inhibitors of microtubule dynamics. Section III concerns using macrocyclic compounds as tubulin inhibitors. In this review, the authors focused primarily on reports produced inthe last five years and the latest strategies in this field.

摘要

微管(由α-和β-微管蛋白异二聚体组成)是普遍存在的细胞聚合物,是细胞骨架的重要组成部分,在细胞内发挥多种作用,如维持细胞结构、蛋白质运输或细胞分裂过程中的染色体分离。微管蛋白聚合物在有丝分裂中起着关键作用,被认为是治疗癌症的化疗药物的一个极好靶点。本文简要概述了针对微管-微管蛋白聚合/解聚动力学的新型化合物的合成和作用机制。它分为以下几部分:第一部分涉及靶向微管-微管蛋白结合药物的芪衍生物。第二部分介绍了微管动力学的光开关抑制剂。第三部分涉及大环化合物作为微管蛋白抑制剂的应用。在这篇综述中,作者主要关注了过去五年内的报道和该领域的最新策略。

相似文献

1
Development of novel derivatives of stilbene and macrocyclic compounds as potent of anti-microtubule factors.开发新型二苯乙烯和大环化合物衍生物作为有效的微管抑制剂。
Biomed Pharmacother. 2021 Jan;133:110973. doi: 10.1016/j.biopha.2020.110973. Epub 2020 Dec 2.
2
Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity.作为秋水仙碱位点微管抑制剂的芪衍生物具有抗白血病活性且全身毒性极小。
Am J Hematol. 2008 May;83(5):390-7. doi: 10.1002/ajh.21104.
3
Tubulin-interactive stilbene derivatives as anticancer agents.作为抗癌剂的微管蛋白相互作用的二苯乙烯衍生物。
Cell Mol Biol Lett. 2013 Sep;18(3):368-97. doi: 10.2478/s11658-013-0094-z. Epub 2013 Jul 1.
4
[Progress in the study of tubulin inhibitors].[微管蛋白抑制剂的研究进展]
Yao Xue Xue Bao. 2010 Sep;45(9):1078-88.
5
Tubulin inhibitors: a patent review.微管蛋白抑制剂:专利研究综述。
Expert Opin Ther Pat. 2014 Jan;24(1):69-88. doi: 10.1517/13543776.2014.859247. Epub 2013 Dec 9.
6
Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.作为癌症化疗药物的微管靶向剂:作为稳定剂和去稳定剂的分子杂化物概述
Curr Top Med Chem. 2017;17(22):2523-2537. doi: 10.2174/1568026617666170104145640.
7
Microtubules and resistance to tubulin-binding agents.微管与对微管结合剂的抗性。
Nat Rev Cancer. 2010 Mar;10(3):194-204. doi: 10.1038/nrc2803. Epub 2010 Feb 11.
8
New tubulin targeting agents currently in clinical development.目前正在临床开发中的新型微管蛋白靶向剂。
Expert Opin Investig Drugs. 2008 May;17(5):707-22. doi: 10.1517/13543784.17.5.707.
9
Microtubules: a dynamic target in cancer therapy.微管:癌症治疗中的一个动态靶点。
IUBMB Life. 2008 Mar;60(3):165-70. doi: 10.1002/iub.25.
10
Recent developments in tubulin polymerization inhibitors: An overview.微管蛋白聚合抑制剂的最新进展:综述。
Eur J Med Chem. 2014 Nov 24;87:89-124. doi: 10.1016/j.ejmech.2014.09.051. Epub 2014 Sep 16.

引用本文的文献

1
Polyphenolic compounds as protective agents against cisplatin-induced ototoxicity with molecular mechanisms and clinical potential.多酚类化合物作为顺铂诱导耳毒性的保护剂:分子机制与临床潜力
RSC Med Chem. 2025 Sep 9. doi: 10.1039/d5md00426h.
2
Deciphering the molecular landscape: integrating single-cell transcriptomics to unravel myofibroblast dynamics and therapeutic targets in clear cell renal cell carcinomas.解析分子图谱:整合单细胞转录组学以揭示透明细胞肾细胞癌中肌成纤维细胞的动态和治疗靶点。
Front Immunol. 2024 Mar 18;15:1374931. doi: 10.3389/fimmu.2024.1374931. eCollection 2024.
3
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancer.
OSGIN1 是一种新型的 TUBB3 调节因子,可促进非小细胞肺癌的肿瘤进展和吉非替尼耐药性。
Cell Mol Life Sci. 2023 Aug 30;80(9):272. doi: 10.1007/s00018-023-04931-4.
4
First-in-Class Colchicine-Based Visible Light Photoswitchable Microtubule Dynamics Disrupting Agent.基于秋水仙碱的首创可视光照开关微管动力学干扰剂。
Cells. 2023 Jul 16;12(14):1866. doi: 10.3390/cells12141866.
5
Colchicine of , A Traditional Anti-Inflammatory Medicine, Induces Apoptosis by Activation of Apoptotic Genes and Proteins Expression in Human Breast (MCF-7) and Mouse Breast (4T1) Cell Lines.传统抗炎药物秋水仙碱通过激活人乳腺癌(MCF - 7)和小鼠乳腺癌(4T1)细胞系中的凋亡基因和蛋白质表达来诱导细胞凋亡。
Cell J. 2022 Nov 2;24(11):647-656. doi: 10.22074/cellj.2022.8290.
6
Photopharmacology of Antimitotic Agents.光药理学与抗有丝分裂药物。
Int J Mol Sci. 2022 May 18;23(10):5657. doi: 10.3390/ijms23105657.
7
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment.微管干扰药物:在卵巢上皮癌治疗中的现状与未来作用
Cancers (Basel). 2021 Dec 12;13(24):6239. doi: 10.3390/cancers13246239.
8
Synthesis and Investigations of Building Blocks with Dibenzo[,] Oxepine for Use in Photopharmacology.合成及二苯并[,]氧杂卓砌块在光药理学中的应用研究。
Int J Mol Sci. 2021 Oct 13;22(20):11033. doi: 10.3390/ijms222011033.